Workflow
ImmuCell(ICCC) - 2025 Q2 - Quarterly Results
ImmuCellImmuCell(US:ICCC)2025-07-09 12:00

Overview of Form 8-K Filing (July 9, 2025) This section outlines ImmuCell Corporation's Form 8-K filing on July 9, 2025, covering preliminary Q2 2025 sales and exhibits Announcement of Preliminary Q2 2025 Sales Results ImmuCell Corporation announced preliminary unaudited Q2 2025 product sales, detailed in a furnished press release - The company issued a press release announcing its preliminary, unaudited product sales for the quarter ended June 30, 20256 - The information in the press release is considered "furnished" and not "filed" for the purposes of Section 18 of the Exchange Act, which has legal implications regarding liability7 Exhibits The filing includes a press release with preliminary sales data and a Cover Page Interactive Data File as exhibits Exhibit List | Exhibit No. | Description | | :--- | :--- | | 99.1 | Press Release of ImmuCell Corporation dated July 9, 2025 | | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |